Bank of New York Mellon’s Redhill Biopharma RDHL Stock Holding History

Bank of New York Mellon’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10	Closed	-$9K	–	4590
2022 Q2	$9K	Sell	10 -10	-50%	-$13.7K	﹤0.01%	4557
2022 Q1	$50K	Hold	20	–	–	﹤0.01%	4522
2021 Q4	$52K	Buy	+20	New	+$80K	﹤0.01%	4495
2021 Q2	–	Sell	-22	Closed	-$161K	–	4455
2021 Q1	$161K	Hold	22	–	–	﹤0.01%	4100
2020 Q4	$181K	Hold	22	–	–	﹤0.01%	3999
2020 Q3	$228K	Sell	22 -22	-50%	-$180K	﹤0.01%	3805
2020 Q2	$293K	Buy	44 +10	+29%	+$68.9K	﹤0.01%	3695
2020 Q1	$154K	Hold	34	–	–	﹤0.01%	3802
2019 Q4	$206K	Buy	34 +17	+100%	+$109K	﹤0.01%	3910
2019 Q3	$120K	Hold	17	–	–	﹤0.01%	3999
2019 Q2	$111K	Hold	17	–	–	﹤0.01%	4014
2019 Q1	$141K	Buy	17 +5	+42%	+$39.6K	﹤0.01%	3956
2018 Q4	$67K	Hold	12	–	–	﹤0.01%	4022
2018 Q3	$106K	Hold	12	–	–	﹤0.01%	4032
2018 Q2	$102K	Hold	12	–	–	﹤0.01%	3997
2018 Q1	$62K	Hold	12	–	–	﹤0.01%	4140
2017 Q4	$62K	Hold	12	–	–	﹤0.01%	4173
2017 Q3	$130K	Hold	12	–	–	﹤0.01%	3958
2017 Q2	$103K	Buy	12 +1	+9%	+$9.61K	﹤0.01%	4022
2017 Q1	$101K	Buy	+11	New	+$110K	﹤0.01%	4029

Other funds holding RDHL

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Bank of New York Mellon's RDHL Position: Q3 2022 in Review

Bank of New York Mellon sold out of Redhill Biopharma (RDHL) in Q3 2022, closing a stake of 10 shares — an estimated $9K sold.

Bank of New York Mellon first reported a position in RDHL in Q1 2017 and held it in 20 quarters. The position peaked at $293K in Q2 2020. 40 funds tracked by Wall St. Rank hold RDHL as of Q3 2022.

Bank of New York Mellon reported no remaining Redhill Biopharma position as of Q3 2022 after selling out during the quarter.
Bank of New York Mellon sold 10 Redhill Biopharma shares in Q3 2022, an estimated $9K.
Bank of New York Mellon first reported a position in Redhill Biopharma in Q1 2017 and held it in 20 quarters.
Bank of New York Mellon's Redhill Biopharma position peaked at $293K in Q2 2020.
40 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2022.

Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.